Tag Archives: Treatment

FDA Approves Blenrep (belantamab mafodotin-blmf) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

FDA Approves Blenrep (belantamab mafodotin-blmf) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma Print this page London UK 05 August 2020 — GlaxoSmithKline announced the US Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf) as a monotherapy treatment for adult patients with relapsed or refractory multiple myeloma who have received… Read More »

The Fitter Do Better After an A-Fib Treatment

MONDAY, Aug 3, 2020 — Physically fit patients with the irregular heartbeat atrial fibrillation (AF) are most likely to benefit from ablation, a new study finds. Patients who are less fit are hospitalized more often, continue to use anti-arrhythmic drugs longer and have higher death rates, researchers say. “AF does not occur in a vacuum… Read More »